Teladoc Health Q1 2026 Earnings EPS Misses Expectations as Cost Pressures Persist RELX Q2 2025 Earnings Narrow EPS Beat with Slight Stock Decline CABA Q1 2026 Earnings NarrowerThanExpected Loss Highlights Progress in Autoimmune Pipeline BVN Q4 2025 Earnings Massive EPS Beat of 122 Driven by Strong Operational Performance Milestone Pharmaceuticals MIST Q1 2026 Earnings EPS Miss Deepens as ClinicalStage Biotech Navigates Development Path Lear Corporation LEA Q1 2026 Earnings Strong EPS Beat Drives Stock Rally Amid Supply Chain Improvements